Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment

NCT01245894 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction [C14.907.585.500]

Interventions

DRUG: Low-dose Rosuvastatin
DRUG: High-dose Rosuvastatin

Sponsor

Odense University Hospital